Unibest

Pharmaceutical intermediates

Parecoxib sodium Intermediates

1 pharmaceutical intermediate for Parecoxib sodium. Indication: Pain, Postoperative.

Submit a ProjectAll intermediates

About Parecoxib sodium

Originator
Pfizer Inc
Indication
Pain, Postoperative
Approved Date
03/22/2022

Available intermediates

1 intermediate currently listed for Parecoxib sodium. Request specifications, documentation or a quotation for any item below.

Parecoxib sodium intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
5-Methyl-3,4-diphenylisoxazole37928-17-9//

Other programs under P

PacritinibPalbociclibParicalcitolPaxlovidPazopanib HydrochloridePeficitinib HydrobromidePemafibratePeramivir

Building toward Parecoxib sodium?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

Submit a Project Talk to the team

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →